Literature DB >> 23143687

Treatment of severe acute graft-versus-host disease with mesenchymal stromal cells: a comparison with non-MSC treated patients.

Mats Remberger1, Olle Ringdén.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23143687     DOI： 10.1007/s12185-012-1218-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  9 in total

1.  Variables predicting deep fungal infections in bone marrow transplant recipients.

Authors:  J Tollemar; O Ringdén; L Boström; B Nilsson; B Sundberg
Journal:  Bone Marrow Transplant       Date:  1989-11       Impact factor: 5.483

2.  Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex.

Authors:  K Le Blanc; L Tammik; B Sundberg; S E Haynesworth; O Ringdén
Journal:  Scand J Immunol       Date:  2003-01       Impact factor: 3.487

3.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

Review 4.  Immunomodulation by mesenchymal stem cells and clinical experience.

Authors:  K Le Blanc; O Ringdén
Journal:  J Intern Med       Date:  2007-11       Impact factor: 8.989

5.  Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.

Authors:  Olle Ringdén; Mehmet Uzunel; Ida Rasmusson; Mats Remberger; Berit Sundberg; Helena Lönnies; Hanns-Ulrich Marschall; Aldona Dlugosz; Attila Szakos; Zuzana Hassan; Brigitta Omazic; Johan Aschan; Lisbeth Barkholt; Katarina Le Blanc
Journal:  Transplantation       Date:  2006-05-27       Impact factor: 4.939

6.  Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy.

Authors:  Lena von Bahr; Berit Sundberg; Lena Lönnies; Birgitta Sander; Holger Karbach; Hans Hägglund; Per Ljungman; Britt Gustafsson; Helen Karlsson; Katarina Le Blanc; Olle Ringdén
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-04       Impact factor: 5.742

7.  Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.

Authors:  O Blennow; M Remberger; L Klingspor; B Omazic; K Fransson; P Ljungman; J Mattsson; O Ringdén
Journal:  Bone Marrow Transplant       Date:  2010-03-01       Impact factor: 5.483

8.  Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium.

Authors:  M von Bonin; F Stölzel; A Goedecke; K Richter; N Wuschek; K Hölig; U Platzbecker; T Illmer; M Schaich; J Schetelig; A Kiani; R Ordemann; G Ehninger; M Schmitz; M Bornhäuser
Journal:  Bone Marrow Transplant       Date:  2008-09-29       Impact factor: 5.483

9.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321
  9 in total
  11 in total

Review 1.  Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease--friends or foes?

Authors:  A Balan; G Lucchini; S Schmidt; A Schneider; L Tramsen; S Kuçi; R Meisel; P Bader; T Lehrnbecher
Journal:  Leukemia       Date:  2014-04-03       Impact factor: 11.528

Review 2.  Stromal cells-are they really useful for GVHD?

Authors:  H Kaipe; T Erkers; B Sadeghi; O Ringdén
Journal:  Bone Marrow Transplant       Date:  2014-01-27       Impact factor: 5.483

Review 3.  Human bone marrow mesenchymal stromal/stem cells: current clinical applications and potential for hematology.

Authors:  Yasuo Miura
Journal:  Int J Hematol       Date:  2015-12-21       Impact factor: 2.490

Review 4.  Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications.

Authors:  Marta E Castro-Manrreza; Juan J Montesinos
Journal:  J Immunol Res       Date:  2015-04-19       Impact factor: 4.818

Review 5.  Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders.

Authors:  Noriko Sugino; Tatsuo Ichinohe; Akifumi Takaori-Kondo; Taira Maekawa; Yasuo Miura
Journal:  Inflamm Regen       Date:  2017-04-03

6.  Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis.

Authors:  Arjang Baygan; Wictor Aronsson-Kurttila; Gianluca Moretti; Babylonia Tibert; Göran Dahllöf; Lena Klingspor; Britt Gustafsson; Bita Khoein; Guido Moll; Charlotta Hausmann; Britt-Marie Svahn; Magnus Westgren; Mats Remberger; Behnam Sadeghi; Olle Ringden
Journal:  Front Immunol       Date:  2017-07-11       Impact factor: 7.561

7.  Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.

Authors:  Olle Ringden; Arjang Baygan; Mats Remberger; Britt Gustafsson; Jacek Winiarski; Bita Khoein; Guido Moll; Lena Klingspor; Magnus Westgren; Behnam Sadeghi
Journal:  Stem Cells Transl Med       Date:  2018-03-13       Impact factor: 6.940

Review 8.  The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease.

Authors:  Lu Zhao; Shanquan Chen; Panxin Yang; Hongcui Cao; Lanjuan Li
Journal:  Stem Cell Res Ther       Date:  2019-06-21       Impact factor: 6.832

9.  Does Mesenchymal Stromal Cell Count in Pre-autologous Hematopoietic Stem Cell Transplant Peripheral Blood and Apheresis Product Predict for Infectious Complications in the Post-transplant Period?

Authors:  Ankur Jain; Alka Khadwal; Man Updesh Singh Sachdeva; Praveen Bose; Deepesh Lad; Shalmoli Bhattacharya; Gaurav Prakash; Pankaj Malhotra; Neelam Varma; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2021-02-28       Impact factor: 0.915

Review 10.  The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation.

Authors:  Ke Zhao; Qifa Liu
Journal:  J Hematol Oncol       Date:  2016-05-18       Impact factor: 17.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.